Product Name | C8 Ceramide |
Description |
Protein kinase activator |
Purity | >98% (TLC) |
CAS No. | 74713-59-0 |
Molecular Formula | C26H51NO3 |
Molecular Weight | 425.7 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Activator |
Solubility | Soluble in DMSO (25 mg/ml) or 100% ethanol (25 mg/ml) |
Source | Synthetic |
Appearance | White waxy solid |
SMILES | CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)CCCCCCC)O |
InChI | InChI=1S/C26H51NO3/c1-3-5-7-9-10-11-12-13-14-15-16-18-19-21-25(29)24(23-28)27-26(30)22-20-17-8-6-4-2/h19,21,24-25,28-29H,3-18,20,22-23H2,1-2H3,(H,27,30)/b21-19+/t24-,25+/m0/s1 |
InChIKey | APDLCSPGWPLYEQ-WRBRXSDHSA-N |
Safety Phrases |
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
Cite This Product | C8 Ceramide (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-499) |
Alternative Names | C8-Ceramide |
Research Areas | Cell Signaling |
PubChem ID | 5702614 |
Scientific Background | C8 Ceramide is a biologically active ceramide analog. It is a protein kinase activator. It has also been shown to induce phosphorylation of EGF, as well as, apoptosis in vitro. |
References |
1. Józefowski S., et al. (2010) J. Immun. (Baltimore, Md.: 1950). 185(11): 6960–6973. 2. Gusain A., et al. (2012) Mol.Neurobio. 45(3): 455–464. |
Reviews
There are no reviews yet.